Literature DB >> 7068219

Purification and certain properties of a bacteriocin from Streptococcus mutans.

T Ikeda, T Iwanami, M Hirasawa, C Watanabe, J R McGhee, T Shiota.   

Abstract

An inhibition factor from Streptococcus mutans strain C3603 (serotype c) was purified and isolated, and its properties indicated that it was a bacteriocin. Bacteriocin C3603 is a basic protein with a pI value of 10 and a molecular weight of 4,800. The activity of this bacteriocin was not affected by pH over a range of 1.0 to 12.0 or by storage at 100 degrees C for 10 min at pH 2.0 to 7.0 or storage at 121 degrees C for 15 min at pH 4.0. Pronase; papain, phospholipase C, trypsin, and alpha-amylase had no effect on the activity of the bacteriocin, whereas alpha-chymotrypsin and pancreatin were partially active against it. Bacteriocin activity was greater against certain S. mutans strains of serotypes b, c, e, and f than against certain S. mutans strains of serotypes a, d, and g. Bacteriocin C3603 was also effective against selected strains of S. sanguis, S. salivarius, S. bovis, S. faecium, S. lactis, Lactobacillus casei, L. plantarum, L. fermentum, Bifidobacterium bifidum, Bifidobacterium longum, Propionibacterium acnes, and Bacteroides melaninogenicus, but it was not effective against certain strains of Escherichia coli, Klebsiella pneumoniae, Corynebacterium parvum, and Candida albicans. The inhibition of S. mutans strains BHT and PS-14 by bacteriocin C3603 was found to be due to the bacteriocidal activity of the bacteriocin. When water or a diet containing bacteriocin C3603 was consumed by gnotobiotic and specific pathogen-free rats infected with S. mutans PS-14, the caries score was found to be significantly reduced.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068219      PMCID: PMC351126          DOI: 10.1128/iai.35.3.861-868.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Dental caries in the molar teeth of rats. II. A method for diagnosing and scoring several types of lesions simultaneously.

Authors:  P H KEYES
Journal:  J Dent Res       Date:  1958 Nov-Dec       Impact factor: 6.116

2.  Production and properties of bacteriocins (mutacins) from Streptococcus mutans.

Authors:  S Hamada; T Ooshima
Journal:  Arch Oral Biol       Date:  1975-10       Impact factor: 2.633

3.  Taxonomy of the oral Streptococcus mutans based on colonial characteristics and serological, biochemical and genetic features.

Authors:  T Ikeda; K Ochiai; T Shiota
Journal:  Arch Oral Biol       Date:  1979       Impact factor: 2.633

4.  Four types of Streptococcus mutans based on their genetic, antigenic and biochemical characteristics.

Authors:  A L Coykendall
Journal:  J Gen Microbiol       Date:  1974-08

5.  Bacteriocins from human and rodent streptococci.

Authors:  J Kelstrup; R J Gibbons
Journal:  Arch Oral Biol       Date:  1969-03       Impact factor: 2.633

6.  The relationship between extracellular polysaccharide-producing streptococci and smooth surface caries in 13-year-old children.

Authors:  J D De Stoppelaar; J Van Houte; O Backer Dirks
Journal:  Caries Res       Date:  1969       Impact factor: 4.056

7.  Extraction, purification, and chemical and immunological properties of the Streptococcus mutans group "a" polysaccharide cell wall antigen.

Authors:  H Mukasa; H D Slade
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

8.  Isolation and characterization of a Streptococcus mutans bacteriocin inhibitor from Streptococcus pyogenes.

Authors:  D Perry; H D Slade
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

9.  Longitudinal investigation of the role of Streptococcus mutans in human fissure decay.

Authors:  W J Loesche; L H Straffon
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

10.  Antigenic relatedness of glucosyltransferase enzymes from streptococcus mutans.

Authors:  D J Smith; M A Taubman
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more
  18 in total

1.  Mechanisms of antibacterial action of tachyplesins and polyphemusins, a group of antimicrobial peptides isolated from horseshoe crab hemocytes.

Authors:  M Ohta; H Ito; K Masuda; S Tanaka; Y Arakawa; R Wacharotayankun; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

2.  Genetic stability of the antagonistic character of Enterococcus faecalis ssp. liquefaciens and the detection of a new inhibitory bacteriocin-like substance.

Authors:  M Martínez-Bueno; A Gálvez; M Maqueda; E Valdivia
Journal:  Folia Microbiol (Praha)       Date:  1990       Impact factor: 2.099

3.  Permeation of bacterial cells, permeation of cytoplasmic and artificial membrane vesicles, and channel formation on lipid bilayers by peptide antibiotic AS-48.

Authors:  A Gálvez; M Maqueda; M Martínez-Bueno; E Valdivia
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

4.  Antagonistic effect of oral bacteria towards Treponema denticola.

Authors:  D Grenier
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Purification and amino acid composition of peptide antibiotic AS-48 produced by Streptococcus (Enterococcus) faecalis subsp. liquefaciens S-48.

Authors:  A Gálvez; G Giménez-Gallego; M Maqueda; E Valdivia
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

6.  Mutacin production by Streptococcus mutans may promote transmission of bacteria from mother to child.

Authors:  L Grönroos; M Saarela; J Mättö; U Tanner-Salo; A Vuorela; S Alaluusua
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.

Authors:  Adam Pepperney; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

8.  Effect of peptide AS-48 on Enterococcus faecalis subsp. liquefaciens S-47.

Authors:  A Galvez; E Valdivia; M Martinez; M Maqueda
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

9.  Isolation of a Streptococcus mutans strain producing a novel bacteriocin.

Authors:  J D Hillman; K P Johnson; B I Yaphe
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

10.  Mode of inhibitory action of a bacteriocin produced by Streptococcus mutans C3603.

Authors:  K Takada; T Ikeda; I Mitsui; T Shiota
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.